Hedge Fund - Camber Capital Management
Biomarin Pharmaceutical Inc (BMRN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $32,982,000 | 3.1% | 600,000 | $58.89 |
| 2 | 2025 - Q1 (2025-03-31) | $35,345,000 | 1.26% | 500,000 | $67.28 |
| 3 | 2024 - Q4 (2024-12-31) | $29,579,000 | 0.68% | 450,000 | $66.98 |
| 4 | 2024 - Q3 (2024-09-30) | $0 | 0% | 0 | $83.59 |
| 5 | 2024 - Q2 (2024-06-30) | $90,563,000 | 2.5% | 1,100,000 | $83.25 |
| 6 | 2024 - Q1 (2024-03-31) | $21,835,000 | 0.53% | 250,000 | $89.52 |
| 7 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $88.47 |
| 8 | 2023 - Q3 (2023-09-30) | $26,544,000 | 0.87% | 300,000 | $88.98 |
| 9 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $93.88 |
| 10 | 2022 - Q3 (2022-09-30) | $67,816,000 | 2.07% | 800,000 | $89.04 |
| 11 | 2022 - Q2 (2022-06-30) | $124,305,000 | 5.39% | 1,500,000 | $79.62 |
| 12 | 2022 - Q1 (2022-03-31) | $100,230,000 | 3.62% | 1,300,000 | $83.67 |
| 13 | 2021 - Q4 (2021-12-31) | $89,675,000 | 3.08% | 1,015,000 | $82.51 |
| 14 | 2021 - Q3 (2021-09-30) | $88,884,000 | 2.73% | 1,150,000 | $78.90 |
| 15 | 2020 - Q4 (2020-12-31) | $0 | 0% | 0 | $79.28 |
| 16 | 2020 - Q3 (2020-09-30) | $30,432,000 | 1.6% | 400,000 | $101.18 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center